Health Care Analysis 7 (3):273-287 (1999)

Abstract
This paper discusses the hazards of regulating controversial biomedical research in light of the emergence of powerful, multi-national biotechnology corporations. Prohibitions on the use of government funds can simply force controversial research into the private sphere, and unilateral or multilateral research bans can simply encourage multi-national companies to conduct research in countries that lack restrictive laws. Thus, a net effect of government regulation is that research migrates from the public to the private sphere. Because private research receives less oversight and external scrutiny than public research, it can threaten the welfare and rights of human subjects, scientific progress and openness, and the quality of the approval process for new biomedical technologies. In order to avoid the harmful effects of government regulation of biotechnology, society should promote meaningful discussion and dialogue among scientists, industry leaders, and the public before resorting to regulatory solutions. Legislative or executive initiatives should be applied with great discretion and care, and should be crafted in such a way that they protect public health and safety, promote scientific progress, and avoid the hazards of privatized research and polarized debates
Keywords biomedical research  government regulation  biotechnology industry  privatization  scientific progress  public debates
Categories (categorize this paper)
DOI 10.1023/A:1009405027357
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 54,466
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Financial Interests and Research Bias.David B. Resnik - 2000 - Perspectives on Science 8 (3):255-285.
Difficulties with Regulating Sex Selection.David B. Resnik - 2001 - American Journal of Bioethics 1 (1):21 – 22.

Add more citations

Similar books and articles

Scientific Self-Regulation—so Good, How Can It Fail?Patrick L. Taylor - 2009 - Science and Engineering Ethics 15 (3):395-406.
Moral Complicity in Induced Pluripotent Stem Cell Research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Ethics, Regulation, and Biomedical Research.Matthew Weed - 2004 - Kennedy Institute of Ethics Journal 14 (4):361-368.
Against One-Size-Fits-All Research Ethics.Michelle N. Meyer - 2010 - Hastings Center Report 40 (5):10-11.
Stem Cell Research and Economic Promises.Timothy Caulfield - 2010 - Journal of Law, Medicine and Ethics 38 (2):303-313.

Analytics

Added to PP index
2010-09-02

Total views
22 ( #461,112 of 2,381,093 )

Recent downloads (6 months)
1 ( #560,102 of 2,381,093 )

How can I increase my downloads?

Downloads

My notes